chr5-53096929-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_004531.5(MOCS2):c.*1673T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0531 in 152,310 control chromosomes in the GnomAD database, including 741 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.053 ( 741 hom., cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MOCS2
NM_004531.5 3_prime_UTR
NM_004531.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.137
Genes affected
MOCS2 (HGNC:7193): (molybdenum cofactor synthesis 2) Eukaryotic molybdoenzymes use a unique molybdenum cofactor (MoCo) consisting of a pterin, termed molybdopterin, and the catalytically active metal molybdenum. MoCo is synthesized from precursor Z by the heterodimeric enzyme molybdopterin synthase. The large and small subunits of molybdopterin synthase are both encoded from this gene by overlapping open reading frames. The proteins were initially thought to be encoded from a bicistronic transcript. They are now thought to be encoded from monocistronic transcripts. Alternatively spliced transcripts have been found for this locus that encode the large and small subunits. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 5-53096929-A-G is Benign according to our data. Variant chr5-53096929-A-G is described in ClinVar as [Benign]. Clinvar id is 906212.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOCS2 | NM_004531.5 | c.*1673T>C | 3_prime_UTR_variant | 7/7 | ENST00000396954.8 | NP_004522.1 | ||
MOCS2 | NM_176806.4 | c.*2160T>C | 3_prime_UTR_variant | 7/7 | ENST00000450852.8 | NP_789776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOCS2 | ENST00000396954.8 | c.*1673T>C | 3_prime_UTR_variant | 7/7 | 1 | NM_004531.5 | ENSP00000380157 | P1 | ||
MOCS2 | ENST00000450852.8 | c.*2160T>C | 3_prime_UTR_variant | 7/7 | 1 | NM_176806.4 | ENSP00000411022 | |||
MOCS2 | ENST00000361377.8 | c.*2009T>C | 3_prime_UTR_variant | 6/6 | 4 | ENSP00000355160 |
Frequencies
GnomAD3 genomes AF: 0.0531 AC: 8079AN: 152192Hom.: 740 Cov.: 33
GnomAD3 genomes
AF:
AC:
8079
AN:
152192
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 12Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 12
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
12
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
12
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.0531 AC: 8086AN: 152310Hom.: 741 Cov.: 33 AF XY: 0.0511 AC XY: 3805AN XY: 74488
GnomAD4 genome
AF:
AC:
8086
AN:
152310
Hom.:
Cov.:
33
AF XY:
AC XY:
3805
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
34
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at